Literature DB >> 14609219

Regulatory cells in transplantation.

Kathryn J Wood1, Hidetake Ushigome, Mahzuz Karim, Andrew Bushell, Shohei Hori, Shimon Sakaguchi.   

Abstract

Regulatory T cells can play an important role in both the induction and maintenance of tolerance to donor alloantigens in vivo. Regulatory activity specific for donor alloantingens is enriched amongst CD4+CD25+ T cells in some settings and can be induced by manipulating the immune system before transplantation. Donor alloantigen-specific CD4+CD25+ regulatory T cells can control aggressive CD4+ as well as CD8+ T cells thereby preventing rejection and can mediate linked unresponsiveness. In vivo, donor alloantigen specific CD4+CD25+ cells are dependent on interleukin (IL)10 and CTLA4 for functional activity. These populations of regulatory cells induced by manipulating the adult immune system therefore have properties in common with naturally occurring regulatory T cells. The active regulation/suppression of immune responsiveness to donor alloantigens offers a way to silence aggressive immune responses directed to donor alloantigens thereby preventing damage to the graft from being inflicted. The generation of regulatory T cells with defined alloantigen specificity could provide dynamic control of rejection responses and offers a potential route to permanent graft survival without the need for life-long non-specific immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14609219

Source DB:  PubMed          Journal:  Novartis Found Symp        ISSN: 1528-2511


  10 in total

1.  Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants.

Authors:  David Hongo; Xiaobin Tang; Suparna Dutt; Roland G Nador; Samuel Strober
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

2.  Long-term control of alloreactive B cell responses by the suppression of T cell help.

Authors:  Yijin Li; Lianli Ma; Dengping Yin; JiKun Shen; Anita S Chong
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  CCR8 is expressed by antigen-elicited, IL-10-producing CD4+CD25+ T cells, which regulate Th2-mediated granuloma formation in mice.

Authors:  Christine M Freeman; Bo-Chin Chiu; Valerie R Stolberg; Jerry Hu; Kyriaki Zeibecoglou; Nicholas W Lukacs; Sergio A Lira; Steven L Kunkel; Stephen W Chensue
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

4.  CCR5 is required for regulation of alloreactive T-cell responses to single class II MHC-mismatched murine cardiac grafts.

Authors:  T Nozaki; J M Rosenblum; A D Schenk; D Ishii; R L Fairchild
Journal:  Am J Transplant       Date:  2009-07-28       Impact factor: 8.086

Review 5.  Transplantation tolerance and its outcome during infections and inflammation.

Authors:  Anita S Chong; Maria-Luisa Alegre
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

6.  Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.

Authors:  Preeti Chhabra; Kenneth L Brayman
Journal:  J Transplant       Date:  2011-10-20

7.  Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

Authors:  Kuibeom Ko; Sayuri Yamazaki; Kyoko Nakamura; Tomohisa Nishioka; Keiji Hirota; Tomoyuki Yamaguchi; Jun Shimizu; Takashi Nomura; Tsutomu Chiba; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2005-09-26       Impact factor: 14.307

Review 8.  Transplantation tolerance: lessons from experimental rodent models.

Authors:  Cherry I Kingsley; Satish N Nadig; Kathryn J Wood
Journal:  Transpl Int       Date:  2007-08-17       Impact factor: 3.782

9.  Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals.

Authors:  Amanda K Antons; Rui Wang; Spyros A Kalams; Derya Unutmaz
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.

Authors:  James M Mathew; Jessica H-Voss; Ann LeFever; Iwona Konieczna; Cheryl Stratton; Jie He; Xuemei Huang; Lorenzo Gallon; Anton Skaro; Mohammed Javeed Ansari; Joseph R Leventhal
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.